Sleeping Aids Market size to grow by USD 36,416.19 million from 2022 to 2027, Driven by the growing patient-care services - Technavio

Loading...
Loading...

NEW YORK, March 27, 2023 /PRNewswire/ -- The global sleeping aids market size is estimated to grow by USD 36,416.19 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 6.79% during the forecast period. The growing patient-care services are driving the market growth, although factors such as lack of patient compliance may impede the market growth. For more insights on the historic market data (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

What's New?

  • Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
  • Global competitiveness and key competitor positions 
  • Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - buy the report!

Sleeping Aids Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on type (insomnia, sleep apnea, restless legs syndrome, and others), product (mattress and pillows, sleep apnea devices, and others), and geography (North America, Europe, APAC, South America, and Middle East and Africa).

  • The market share growth by the insomnia segment will be significant for the market growth during the forecast period.  Insomnia causes difficulty falling and/or staying asleep, and it may be acute or persistent. Acute insomnia might continue for a few weeks or just one night whereas chronic insomnia is defined as a sleep disorder where a person experiences trouble sleeping at least three nights per week for three months or more. In 2022, insomnia affected 237 million people worldwide. Therefore, the rising incidence of insomnia is expected to drive the growth of the segment during the forecast period.

Geography Overview
The report provides actionable insights and estimates the contribution of all regions to the growth of the global sleeping aids market.

  • North America is estimated to contribute 35% to the growth of the global market during the forecast period. The market in North America dominates the global sleeping aids market owing to the increasing prevalence of diabetes and the rising number of obese people. The complications of obesity lead to disrupted breathing issues such as snoring and sleep apnea. The increased adoption of CPAP devices has significantly impacted the growth of the market in the region.

Insights on the market contribution of various segments, including country- and region-wise historic data (2017 to 2021) and forecast market size (2023 to 2027) - Download a Sample Report

Sleeping Aids Market – Market Dynamics
Key factor driving market growth 

The growing patient-care services are a major factor driving the growth of the global sleeping aids market. Patient-care services grow with the increasing number of healthcare facilities and are broadly classified into two types, namely healthcare-based patient-care services and home-care-based patient-care services. The number of patients undergoing post-treatment patient care has increased substantially because of the increased incidence of chronic diseases, lifestyle-related diseases, and medical emergencies. During post-treatment patient care, patients need to take rest for a long duration and are highly prone to various skin infections and bedsores. To avoid such issues, pressure-relief mattresses are used as preventive measures.

Leading trends influencing the market 

The growing prevalence of OSA is the primary trend in the global sleeping aids market growth. OSA is a condition characterized by repeatedly interrupted breathing during sleep. It frequently occurs in adults. The prevalence of OSA increases with age and may affect 38% to 68% of people who are older than 60 years. Sleep apnea affects both adults and children, with OSA being the most common type of sleep apnea. Symptoms of OSA in children include issues such as bedwetting, choking or drooling, excessive sweating at night, snoring, and learning and behavioral disorders. However, the improved quality of sleep aided by these devices aids in the retention of existing users, which will lead to the growth of the market during the forecast period.

Major challenges hindering the market growth

The lack of patient compliance is a primary challenge to the growth of the global sleeping aids market. Discomfort is a primary factor that contributes to non-compliance in people using self-care medical devices. Vendors must consider important aspects such as safety, usability, efficacy, comfort, and disposal when designing a device. The low compliance rate with older people may give rise to numerous complications. The complications can be in terms of drug delivery and diagnostics and sometimes may cause injury and the patients should be encouraged to use these devices with better compliance. Treatment effectiveness for OSA is limited despite the high efficacy of CPAP. Hence, the lack of patient compliance may impede market growth.

Insights on market drivers, trends, & challenges, historic period (2017 to 2021), and forecast period (2023 to 2027)- Request a sample report!

What are the key data covered in this Sleeping Aids Market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the sleeping aids market between 2023 and 2027
  • Precise estimation of the size of the sleeping aids market and its contribution to the market with a focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the sleeping aids market across North America, Europe, APAC, South America, and Middle East and Africa
  • A thorough analysis of the market's competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of sleeping aids market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The sleep mask market size is expected to increase by USD 2.14 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.95%. The rapid growth in online sales is one of the key drivers supporting the sleep mask market growth.

The sleeping pods market size is expected to increase to USD 29.59 million from 2021 to 2026, at a CAGR of 5.34%. One of the key factors driving growth in the sleeping pods market is the increase in awareness of the benefits of sleeping pods at the workplace.

Sleeping Aids Market Scope

Report Coverage

Details

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.79%

Market growth 2023-2027

USD 36,416.19 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

6.41

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 35%

Key countries

US, China, Japan, Germany, and France

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abecca, AstraZeneca Plc, Becton Dickinson and Co., Cadwell Industries Inc., Compumedics Ltd., ConnectAmerica, CSL Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Medical Depot Inc., Merck and Co. Inc., Natus Medical Inc., Pfizer Inc., Sanofi SA, Serta Inc., SleepMed Inc., Takeda Pharmaceutical Co. Ltd., Talley Group Ltd., ActiGraph LLC, and Koninklijke Philips NV

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio Health Care market reports       

Table of Contents      

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global sleeping aids market 2017 - 2021 
    • Exhibit 18: Historic Market Size – Data Table on Global sleeping aids market 2017 - 2021 ($ million)
  • 4.2 Type Segment Analysis 2017 - 2021 
    • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021 
    • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition
    • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

  • 6.1 Market segments
    • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
  • 6.2 Comparison by Type
    • Exhibit 32: Chart on Comparison by Type
    • Exhibit 33: Data Table on Comparison by Type
  • 6.3 Insomnia - Market size and forecast 2022-2027 
    • Exhibit 34: Chart on Insomnia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Insomnia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Insomnia - Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Insomnia - Year-over-year growth 2022-2027 (%)
  • 6.4 Sleep Apnea - Market size and forecast 2022-2027 
    • Exhibit 38: Chart on Sleep Apnea - Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on Sleep Apnea - Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on Sleep Apnea - Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Sleep Apnea - Year-over-year growth 2022-2027 (%)
  • 6.5 Restless legs syndrome - Market size and forecast 2022-2027 
    • Exhibit 42: Chart on Restless legs syndrome - Market size and forecast 2022-2027 ($ million)
    • Exhibit 43: Data Table on Restless legs syndrome - Market size and forecast 2022-2027 ($ million)
    • Exhibit 44: Chart on Restless legs syndrome - Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Restless legs syndrome - Year-over-year growth 2022-2027 (%)
  • 6.6 Others - Market size and forecast 2022-2027 
    • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
    • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by Type 
    • Exhibit 50: Market opportunity by Type ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
    • Exhibit 51: Chart on Product - Market share 2022-2027 (%)
    • Exhibit 52: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product 
    • Exhibit 53: Chart on Comparison by Product
    • Exhibit 54: Data Table on Comparison by Product
  • 7.3 Mattress and pillows - Market size and forecast 2022-2027 
    • Exhibit 55: Chart on Mattress and pillows - Market size and forecast 2022-2027 ($ million)
    • Exhibit 56: Data Table on Mattress and pillows - Market size and forecast 2022-2027 ($ million)
    • Exhibit 57: Chart on Mattress and pillows - Year-over-year growth 2022-2027 (%)
    • Exhibit 58: Data Table on Mattress and pillows - Year-over-year growth 2022-2027 (%)
  • 7.4 Sleep apnea devices - Market size and forecast 2022-2027 
    • Exhibit 59: Chart on Sleep apnea devices - Market size and forecast 2022-2027 ($ million)
    • Exhibit 60: Data Table on Sleep apnea devices - Market size and forecast 2022-2027 ($ million)
    • Exhibit 61: Chart on Sleep apnea devices - Year-over-year growth 2022-2027 (%)
    • Exhibit 62: Data Table on Sleep apnea devices - Year-over-year growth 2022-2027 (%)
  • 7.5 Others - Market size and forecast 2022-2027 
    • Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
    • Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
Loading...
Loading...
  • 7.6 Market opportunity by Product 
    • Exhibit 67: Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 69: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 71: Chart on Geographic comparison
    • Exhibit 72: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027 
    • Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
    • Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027 
    • Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
    • Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 APAC - Market size and forecast 2022-2027 
    • Exhibit 81: Chart on APAC - Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on APAC - Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on APAC - Year-over-year growth 2022-2027 (%)
  • 9.6 South America - Market size and forecast 2022-2027 
    • Exhibit 85: Chart on South America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on South America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on South America - Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on South America - Year-over-year growth 2022-2027 (%)
  • 9.7 Middle East and Africa - Market size and forecast 2022-2027 
    • Exhibit 89: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
  • 9.8 US - Market size and forecast 2022-2027 
    • Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027 
    • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 France - Market size and forecast 2022-2027 
    • Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ million)
    • Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ million)
    • Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.11 China - Market size and forecast 2022-2027 
    • Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
    • Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.12 Japan - Market size and forecast 2022-2027 
    • Exhibit 109: Chart on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 110: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 111: Chart on Japan - Year-over-year growth 2022-2027 (%)
    • Exhibit 112: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.13 Market opportunity by geography 
    • Exhibit 113: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 114: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
    • Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
    • Exhibit 116: Overview on factors of disruption
  • 11.4 Industry risks
    • Exhibit 117: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
    • Exhibit 118: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 119: Matrix on vendor position and classification
  • 12.3 ActiGraph LLC
    • Exhibit 120: ActiGraph LLC - Overview
    • Exhibit 121: ActiGraph LLC - Product / Service
    • Exhibit 122: ActiGraph LLC - Key offerings
  • 12.4 Cadwell Industries Inc. 
    • Exhibit 123: Cadwell Industries Inc. - Overview
    • Exhibit 124: Cadwell Industries Inc. - Product / Service
    • Exhibit 125: Cadwell Industries Inc. - Key offerings
  • 12.5 Compumedics Ltd.
    • Exhibit 126: Compumedics Ltd. - Overview
    • Exhibit 127: Compumedics Ltd. - Product / Service
    • Exhibit 128: Compumedics Ltd. - Key offerings
  • 12.6 ConnectAmerica
    • Exhibit 129: ConnectAmerica - Overview
    • Exhibit 130: ConnectAmerica - Product / Service
    • Exhibit 131: ConnectAmerica - Key offerings
  • 12.7 GlaxoSmithKline Plc
    • Exhibit 132: GlaxoSmithKline Plc - Overview
    • Exhibit 133: GlaxoSmithKline Plc - Business segments
    • Exhibit 134: GlaxoSmithKline Plc - Key offerings
    • Exhibit 135: GlaxoSmithKline Plc - Segment focus
  • 12.8 Koninklijke Philips NV 
    • Exhibit 136: Koninklijke Philips NV - Overview
    • Exhibit 137: Koninklijke Philips NV - Business segments
    • Exhibit 138: Koninklijke Philips NV - Key news
    • Exhibit 139: Koninklijke Philips NV - Key offerings
    • Exhibit 140: Koninklijke Philips NV - Segment focus
  • 12.9 Medical Depot Inc.
    • Exhibit 141: Medical Depot Inc. - Overview
    • Exhibit 142: Medical Depot Inc. - Product / Service
    • Exhibit 143: Medical Depot Inc. - Key offerings
  • 12.10 Merck and Co. Inc.
    • Exhibit 144: Merck and Co. Inc. - Overview
    • Exhibit 145: Merck and Co. Inc. - Business segments
    • Exhibit 146: Merck and Co. Inc. - Key news
    • Exhibit 147: Merck and Co. Inc. - Key offerings
    • Exhibit 148: Merck and Co. Inc. - Segment focus
  • 12.11 Natus Medical Inc.
    • Exhibit 149: Natus Medical Inc. - Overview
    • Exhibit 150: Natus Medical Inc. - Product / Service
    • Exhibit 151: Natus Medical Inc. - Key news
    • Exhibit 152: Natus Medical Inc. - Key offerings
  • 12.12 Pfizer Inc.
    • Exhibit 153: Pfizer Inc. - Overview
    • Exhibit 154: Pfizer Inc. - Product / Service
    • Exhibit 155: Pfizer Inc. - Key news
    • Exhibit 156: Pfizer Inc. - Key offerings
  • 12.13 Sanofi SA
    • Exhibit 157: Sanofi SA - Overview
    • Exhibit 158: Sanofi SA - Business segments
    • Exhibit 159: Sanofi SA - Key news
    • Exhibit 160: Sanofi SA - Key offerings
    • Exhibit 161: Sanofi SA - Segment focus
  • 12.14 Serta Inc.
    • Exhibit 162: Serta Inc. - Overview
    • Exhibit 163: Serta Inc. - Product / Service
    • Exhibit 164: Serta Inc. - Key offerings
  • 12.15 SleepMed Inc.
    • Exhibit 165: SleepMed Inc. - Overview
    • Exhibit 166: SleepMed Inc. - Product / Service
    • Exhibit 167: SleepMed Inc. - Key offerings
  • 12.16 Takeda Pharmaceutical Co. Ltd. 
    • Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Overview
    • Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Key news
    • Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 12.17 Talley Group Ltd.
    • Exhibit 172: Talley Group Ltd. - Overview
    • Exhibit 173: Talley Group Ltd. - Product / Service
    • Exhibit 174: Talley Group Ltd. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 175: Inclusions checklist
    • Exhibit 176: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 177: Currency conversion rates for US$
  • 13.4 Research methodology
    • Exhibit 178: Research methodology
    • Exhibit 179: Validation techniques employed for market sizing
    • Exhibit 180: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 181: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE Technavio

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...